RT Journal
A1 Cheng TO
T1 WEight watching in heparin
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 1999
FD May 24
VO 159
IS 10
SP 1142
OP 1142
DO 
UL http://dx.doi.org/
AB 
This success of LMWH in the management of DVT has prompted several investigators to study the use of LMWH in acute coronary syndromes. Three recently completed trials—the FRagmin during InStability in Coronary artery disease study (FRISC),4 the Efficacy and Safety of Subcutaneous Enoxaparin in Non–Q-wave Coronary Events study (ESSENCE),5 and the FRagmin In unstable Coronary artery disease study (FRIC)6—concluded that treatment of patients with unstable angina with LMWH is at least as effective as and potentially more effective than with unfractionated heparin.